NASDAQ:SIEN - Sientra Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $8.20
  • Forecasted Upside: 15.17 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$7.12
▲ +0.02 (0.28%)
1 month | 3 months | 12 months
Get New Sientra Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SIEN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SIEN

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$8.20
▲ +15.17% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Sientra in the last 3 months. The average price target is $8.20, with a high forecast of $11.00 and a low forecast of $5.00. The average price target represents a 15.17% upside from the last price of $7.12.
Buy
The current consensus among 6 polled investment analysts is to buy stock in Sientra. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/15/2019
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/14/2019
  • 0 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/13/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/11/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/9/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/8/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/6/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/8/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/5/2021Maxim GroupReiterated RatingBuy$11.00High
i
Rating by Anthony Vendetti at Maxim Group
2/5/2021Canaccord GenuityBoost Price TargetBuy$6.00 ➝ $8.00High
i
11/10/2020William BlairReiterated RatingOutperformLow
i
Rating by M. Kaczor at William Blair
11/10/2020SVB LeerinkBoost Price TargetOutperform$6.00 ➝ $8.00High
i
8/14/2020Canaccord GenuityReiterated RatingBuy$6.00High
i
8/12/2020Maxim GroupReiterated RatingBuy$8.00High
i
8/11/2020SVB LeerinkBoost Price TargetOutperform$5.30 ➝ $6.00High
i
6/11/2020Maxim GroupBoost Price Target$5.00 ➝ $8.00Low
i
5/15/2020Canaccord GenuityLower Price TargetBuy$9.00 ➝ $5.00Medium
i
5/12/2020SVB LeerinkLower Price TargetOutperform$6.50 ➝ $5.30High
i
3/23/2020StephensLower Price TargetOverweight$10.00 ➝ $5.00High
i
3/12/2020Craig HallumLower Price TargetBuy$14.00 ➝ $9.00High
i
3/12/2020SVB LeerinkLower Price TargetOutperform$13.00 ➝ $6.50High
i
3/12/2020Canaccord GenuityLower Price TargetBuy$13.00 ➝ $9.00High
i
Rating by Kyle Rose at Canaccord Genuity
3/12/2020Maxim GroupLower Price TargetBuy$12.00 ➝ $8.00High
i
3/12/2020StephensLower Price TargetOverweight$14.00 ➝ $10.00High
i
11/5/2019William BlairUpgradeMarket Perform ➝ OutperformMedium
i
Rating by M. Kaczor at William Blair
9/24/2019Canaccord GenuitySet Price TargetBuy$13.00High
i
Rating by Kyle Rose at Canaccord Genuity
8/9/2019StephensSet Price TargetBuy$16.00Low
i
Rating by Chris Cooley at Stephens
8/9/2019Canaccord GenuityBoost Price TargetBuy$11.00 ➝ $13.00N/A
i
8/9/2019Maxim GroupReiterated RatingBuy ➝ Buy$16.00 ➝ $12.00High
i
7/25/2019Craig HallumLower Price TargetBuy$20.00 ➝ $14.00Medium
i
Rating by Alexander Nowak at Craig Hallum
6/5/2019Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$8.00 ➝ $10.00High
i
Rating by David Maris at Wells Fargo & Company
4/22/2019Craig HallumSet Price TargetBuy$23.00Low
i
Rating by Alexander Nowak at Craig Hallum
3/26/2019Craig HallumSet Price TargetBuy$23.00High
i
Rating by Alexander Nowak at Craig Hallum
3/14/2019Wells Fargo & CompanyInitiated CoverageMarket Perform$9.00High
i
3/13/2019Stifel NicolausLower Price TargetBuy$19.00 ➝ $16.00Medium
i
3/13/2019Dougherty & CoLower Price TargetBuy$29.00 ➝ $27.00High
i
3/13/2019SVB LeerinkLower Price Target$22.00 ➝ $18.00High
i
3/13/2019William BlairDowngradeOutperform ➝ Market PerformHigh
i
Rating by M. Kaczor at William Blair
2/11/2019Maxim GroupReiterated RatingBuy$20.00Medium
i
12/19/2018Maxim GroupUpgradeHold ➝ BuyLow
i
8/30/2018Dougherty & CoInitiated CoverageBuy ➝ Buy$31.00Medium
i
Rating by K. Bauser at Dougherty & Co
8/9/2018StephensReiterated RatingBuy$30.00High
i
8/8/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$21.00 ➝ $25.00High
i
8/8/2018Canaccord GenuityBoost Price TargetBuy$19.00 ➝ $25.00High
i
6/4/2018Craig HallumInitiated CoverageBuy$23.00High
i
5/10/2018Canaccord GenuityReiterated RatingBuy$19.00High
i
4/27/2018Lake Street CapitalUpgradeHold ➝ Buy$16.00Low
i
Rating by R. Department at Lake Street Capital
4/26/2018Maxim GroupBoost Price TargetBuy ➝ Buy$15.00 ➝ $19.00Low
i
4/20/2018SVB LeerinkReiterated RatingOutperformHigh
i
Rating by R. Newitter at SVB Leerink LLC
4/19/2018Canaccord GenuityReiterated RatingBuy$18.00High
i
4/19/2018Lake Street CapitalBoost Price TargetHold ➝ Hold$11.00 ➝ $13.00High
i
Rating by R. Department at Lake Street Capital
3/22/2018Maxim GroupInitiated CoverageBuy ➝ Buy$15.00High
i
3/14/2018Canaccord GenuityLower Price TargetBuy ➝ Buy$19.00 ➝ $18.00Low
i
3/1/2018William BlairReiterated RatingBuyLow
i
Rating by M. Kaczor at William Blair
2/21/2018Lake Street CapitalDowngradeBuy ➝ Hold$15.00 ➝ $11.00High
i
Rating by R. Department at Lake Street Capital
1/19/2018Stifel NicolausUpgradeHold ➝ Buy$14.00High
i
1/5/2018Canaccord GenuityReiterated RatingBuy$19.00High
i
10/8/2017Canaccord GenuityReiterated RatingBuy$14.00N/A
i
9/27/2017Stifel NicolausReiterated RatingHold ➝ Hold$11.00 ➝ $14.00High
i
9/13/2017William BlairUpgradeMarket Perform ➝ OutperformHigh
i
Rating by M. Kaczor at William Blair
8/28/2017Canaccord GenuityInitiated CoverageBuy ➝ Buy$14.00High
i
8/8/2017Lake Street CapitalReiterated RatingBuy$11.00 ➝ $15.00Low
i
8/2/2017Lake Street CapitalReiterated RatingBuy ➝ Buy$11.00 ➝ $15.00High
i
7/11/2017StephensInitiated CoverageOverweight$12.00High
i
4/17/2017Lake Street CapitalInitiated CoverageBuy ➝ Buy$11.00High
i
8/10/2016William BlairReiterated RatingMarket PerformN/A
i
Rating by M. Kaczor at William Blair
(Data available from 3/8/2016 forward)
Sientra logo
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, OPUS, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Read More

Today's Range

Now: $7.12
$6.62
$7.24

50 Day Range

MA: $6.35
$4.39
$8.59

52 Week Range

Now: $7.12
$1.00
$8.93

Volume

79,486 shs

Average Volume

1,263,839 shs

Market Capitalization

$359.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.81

Frequently Asked Questions

What sell-side analysts currently cover shares of Sientra?

The following Wall Street sell-side analysts have issued research reports on Sientra in the last year: Canaccord Genuity, Craig Hallum, Maxim Group, Stephens, SVB Leerink LLC, William Blair, and Zacks Investment Research.
View the latest analyst ratings for SIEN.

What is the current price target for Sientra?

5 Wall Street analysts have set twelve-month price targets for Sientra in the last year. Their average twelve-month price target is $8.20, suggesting a possible upside of 15.2%. Maxim Group has the highest price target set, predicting SIEN will reach $11.00 in the next twelve months. Stephens has the lowest price target set, forecasting a price of $5.00 for Sientra in the next year.
View the latest price targets for SIEN.

What is the current consensus analyst rating for Sientra?

Sientra currently has 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SIEN will outperform the market and that investors should add to their positions of Sientra.
View the latest ratings for SIEN.

What other companies compete with Sientra?

How do I contact Sientra's investor relations team?

Sientra's physical mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier's listed phone number is 805-562-3500 and its investor relations email address is [email protected] The official website for Sientra is www.sientra.com.